Report Store Get Proposal

Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!

Home Blog Oncology 50

Oncology

pharma-biotech-news-and-updates-for-dna-link-base10-takeda-advaxis

Notizia - Recent Pharma, Healthcare and Biotech Happenings

BASE10 Collaboration; Advaxis Public offerings; Takeda’s CABOMETYX Japan approval; TheraPharm Acquisition

BASE10 Collaborates with DNA Link for COVID-19 Antibody Test Research US-based BASE10 Genetics and Korean firm DNA Link announced a collaboration on a research project to appraise the usability of the DNA Link's antibody test, AccuFind COVID-19 IgG, in a healthcare setting. Currently, most antibody tests available in the market need the samples to be sent to the lab for further analysis, which adds to the time as well as cost. Thus, a test that can be done at the point of care and quickly provide the information to clinicians to move with the treatments will prove beneficial in many ways. The research is an important step towards evaluating and expandin...

Explore More...

Default Blog Image

LAG-3 Antagonists, TIM-3 Antagonists; OX40 Agonists- Pipeline Insights, 2016 – A DelveInsight Report

Default Blog Image

Chimeric Antigen Receptor T cell Immunotherapy Market Analysis and Forecast

Default Blog Image

Zemplar Drug Insights, 2016

Default Blog Image

Head and Neck Squamous Cell Carcinoma -Pipeline Insights, 2016

Default Blog Image

Pancreatic Cancer-Pipeline Insights, 2016

Default Blog Image

Peripheral Lung Cancer Pipeline Insights, 2016

Default Blog Image

Small interfering RNA (siRNA) Therapeutics

Default Blog Image

“Endometrial Cancer – Pipeline Insights, 2015”- A DelveInsight’s Report

Default Blog Image

PD-1 and PD-L1 inhibitors – Competitive Landscape, Pipeline and Market Analysis, 2015 – A DelveInsight Report

Default Blog Image

Bile Duct Cancer (Cholangiocarcinoma) -Pipeline Insights, 2015

Default Blog Image

Oral Mucositis Pipeline Insights, 2015- A DelveInsight Report

Cytotoxic T lymphocyte-associated antigen-4 Market Forecast & Insights

DelveInsight’s Oncology based Reports, 2015

Default Blog Image

DelveInsight launches Indication Active Pharmaceutical Ingredient (API) Reports

Default Blog Image

Chimeric Antigen Receptor T cell Therapy Market

Default Blog Image

Chimeric Antigen Receptor T-cell Therapy Landscape

Subscribe to our Updates

DelveInsight is dedicated to safeguarding your data. We ensure that your information is handled in compliance with relevant data privacy legislation, our internal guidelines, and our privacy policy.

Receive recent Healthcare updates directly in your inbox.

Daily

Weekly

Monthly